Clinical trial
Effect of Combination Therapy With Two Drugs (Colesevelam and Ezetimibe) in…
NCT00185107 · Daiichi Sankyo, Industry · Completed
Key facts
| NCT number | NCT00185107 |
|---|---|
| Title | Effect of Combination Therapy With Two Drugs (Colesevelam and Ezetimibe) in Patients With High Cholesterol |
| Official title | A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of WelChol® in Combination With Zetia® Compared to Zetia® Alone in Patients With Primary Hypercholesterolemia |
| Lead sponsor | Daiichi Sankyo, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | Colesevelam Hydrochloride, Ezetimibe, Simvastatin |
| Enrollment | 45 |
| Start date | Mar 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 11, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: